Krka, d.d., Novo Mesto
KRKG · LJSE · Pharmaceuticals
公司简介
Krka is a Slovenian generic pharmaceutical company headquartered in Novo Mesto, ranked among the top 10 generic drug makers in Europe and 16th globally. The group generates revenues primarily from prescription generics, over-the-counter medicines, and veterinary products, with Eastern Europe representing its largest regional market. In 2024, group revenue reached approximately €1.9 billion, up 6% year-on-year, with a record operating profit of €408 million.
| 交易所 | LJSE |
| 股票代码 | KRKG |
| 行业 | Pharmaceuticals |
| 参考市值 美元 | $4.42B |
| 网站 | 访问官网 |
实时报价
正在加载实时价格……
| 市值 | |
| 当日区间 | |
| 52周区间 |
购买渠道
在其本地市场（LJSE），可通过以下提供该交易所准入的全球券商进行投资：
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Ljubljana Stock Exchange — 官方交易所上市信息
仅为准入信息参考，不构成推荐或购买要约。请向您的券商确认资格、费用及当前可用性。
Slovenia的其他公司
公司数据及任何实时价格均为参考性质，可能存在延迟或不准确，仅供研究参考，不构成投资建议。请以交易所、公司公告及您的券商信息为准。